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Abstract
The UK breast screening programme (UK BSP) is organised into a large number of
individual screening units. Decision makers need to ensure these units are producing
efficiently, particularly as the programme is anticipated to expand. Data envelopment
analysis (DEA) was applied to investigate: the relative efficiency of screening units; the
impact of screening unit size on efficiency; and how individual units could improve.
Sixty-four screening units were categorised into 33 large and 31 small. Data were collected
using a national survey and routinely collected data. The overall median efficiency score was
91%, 39 units were inefficient. Variation in efficiency scores was wide. Large units had a
median efficiency score of 100% and 12 units were inefficient. Smaller units had a median
efficiency score of 95% and 19 were inefficient. This difference was not statistically significant
(Mann–Whitney, P0.076). Forty-two percent of large units and 21% of small units were
operating at constant returns to scale (mean difference 0.20, 95% CI: 0.15–0.43). Although
there is no systematic difference in efficiency by size of screening unit there are inefficiencies
in both large and small units and there is scope for many individual units to improve their
use of current resources. It will be necessary for decision-makers to examine the practices of
individual screening units before considering options for how best to improve their resource
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use. DEA can help to identify feasible options. © 2001 Elsevier Science Ireland Ltd. All
rights reserved.
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1. Introduction
The UK governments invest heavily in breast screening, spending around 63.6
million Euro’s each year on the UK breast screening programme (UK BSP) to
purchase a sizeable and specialist set of health care inputs. The programme is
organised into a large number of individual screening units, each having autonomy
over how it produces the outputs of breast screening (invitations, screens and
cancers detected).
Now in its 11th year of operation, the UK BSP is currently facing a number of
challenges. There is a shortage of professional staff, particularly radiologists.
Anticipated changes in screening policies, such as the extension of the upper age
range for screening, expansions to women at familial risk of breast cancer, as well
as increasing demographic pressures, have created additional demands. These
challenges mean that decision makers in the UK BSP need to have information on
the performance of individual screening units and, in particular, whether resources
are currently being used efficiently.
To address the relative efficiency of individual screening units, a suitable perfor-
mance indicator is required. To date, the performance indicators in the UK BSP
have not focused on efficiency per se but have measured uptake, recall and cancer
detection rates. These routinely collected performance indicators have suggested
that the programme continues to achieve high levels of acceptance (in terms of
uptake rates) and to offer a quality service (in terms of recall and cancer detection
rates), although there is variation across the UK [1–3]. Such performance indica-
tors, however, have limitations.
First, they do not measure all outputs simultaneously and instead measure
uptake, recall and cancer detection rates independently. Second, such performance
indicators ignore the levels and types of inputs and, in turn, the relationship
between inputs and outputs. There may be considerable differences in the way in
which different units combine their inputs to produce their outputs. Furthermore,
such differences may vary according to the scale of production.
The ideal performance measure for breast screening units would be one that
addressed the relationship between multiple inputs and outcomes. In addition, it is
most appropriate for breast screening units to have their efficiency judged relative
to those with which they are broadly similar in terms of input:output orientation.
If this is not the case then inter alia managers of one unit may argue that it is
‘unfair’ to be compared with another that which they consider to be different in
some important dimension. One particular difficulty with measuring the perfor-
mance of breast screening units is the potential for the interpretation of cancer data
to be confounded. This arises because cancer detection rates may vary geographi-
K. Johnston, K. Gerard : Health Policy 56 (2001) 21–32 23
cally. They ought as a result to be adjusted for background incidence of breast
cancer in the geographical area that the unit serves. (A correction factor has
recently been produced by Blanks and Moss [4] and can be used to overcome
this issue.) Cancer detection rates may also be confounded by the problem of a
small numbers. If a unit screens a small number of women and picks up, for
example, 10 cancers, the cancer detection rate would be very high. Similarly, if a
unit screens a small number of women but does not detect any cancers this
would lead to a zero cancer detection rate. Consequently, the cancer detection
rate of very small units can be subject to marked spurious variations making it
necessary to adjust for this in subsequent analysis.
2. Size of screening unit
The size of a screening unit can be measured by its eligible population, which
is the number of women of screening age (aged 50–64) who reside in the
catchment area. Since the interval of screening is 3-yearly, the number of women
invited for screening annually is approximately one-third of the eligible popula-
tion. Although a screening unit may operate both static and mobile screening,
the size of screening unit is defined by the total eligible population. When the
UK BSP was set up, the Forrest Committee [5], whose role it was to make
initial recommendations for screening policies and practices, provided some guid-
ance on the size of the eligible population each screening unit should serve. The
size of a screening unit was estimated on the basis of its’ serving a population of
471 000, an eligible screening population of 41 150 women over a 3-year cycle
and implying a total of approximately 12 000 screens per year [5]. The Commit-
tee also recognised, however, that the exact specification of a unit’s requirements
would depend on the uptake, recall and cancer detection rates. A steady state
pattern of screening has now been established throughout the UK [6]. Fig. 1
shows there is a wide range in the size of screening units with the smallest
serving an eligible screening population of less than 20 000 women and the
largest over 140 000.
Although the Forrest Committee suggested an eligible screening population of
41 150, it is not known what the efficient size is. Efficiency may be affected by
size because larger units are more able to operate under conditions of economies
of scale, that is, spread a larger output over the fixed inputs. This type of issue
has been explored in terms, for example, of the size of acute hospitals and
whether to concentrate acute services into fewer but larger hospitals [7,8]. Cur-
rent knowledge, however, suggests that the relationship between hospital volume
and health outcomes cannot be generalised and that there is only limited evi-
dence to support the claim that larger hospitals benefit from economies of scale
[9]. In fact, some economies can occur in small hospitals (less than 200 beds) [9].
Thus, it is not necessarily the case that larger screening units will be more
efficient as a result of economies of scale. There may be other reasons why large
and small screening units differ in terms of efficiency. For example, larger units
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may be less efficient than smaller units because of a higher level of administra-
tion staff, but they may be more efficient than smaller units if they can deploy
radiologists more efficiently. Smaller units may be less efficient than larger units
because they have lower levels of specialist staff, such as an assessment
team. Another issue with smaller units is that they may be preferred by women
if they are more accessible in terms of distance travelled. All these arguments
suggest that determining whether efficiency differs by size of breast screening
unit is an important policy issue. There is currently no evidence of efficiency by
size of screening unit in the UK or other countries with national screening
programmes.
3. Assessing efficiency using data envelopment analysis
One approach to measuring efficiency is data envelopment analysis (DEA).
This can be used to assess relative efficiency of productive units. Efficiency is
concerned with the relationship between the inputs and outputs of a productive
unit and occurs where a productive unit is organised to minimise its use of
inputs from a set of outputs. In this case efficiency would be concerned with
how breast screening units are organised, say, to minimise their use of inputs
(deployment of administration, medical and radiographic staff with mammogra-
phy machines) to produce invitations, screens and cancers detected.
DEA is a non-parametric, mathematical programming technique, using data
from a sample of units to generate a single measure of efficiency for each unit
and an efficiency score across units (ranging from 0%, completely inefficient, to
100% completely efficient). The efficiency score of a productive unit is defined by
its position relative to the frontier of best performance, which is established
mathematically by the ratio of the weighted sum of outputs to the weighted sum
of inputs [10]. The efficiency score of a productive unit that is not on the
frontier is estimated by comparing it with those efficient productive units on the
frontier with the most similar input:output orientation (peers). Efficiency scores
can be used to identify and describe efficient and inefficient units, units of best
practice (peers) for a particular inefficient unit, and scale inefficiencies. The anal-
ysis may also be used to quantify potential targets for improving inefficient units
[11]. DEA has been portrayed as a useful economic tool to measure the relative
efficiency of health service productive units performing similar tasks [12]. Its
usefulness is attributed to its appropriateness in the multiple input:output envi-
ronment of much of health care provision and the simplicity of the assumptions
that underlie the method.
Using data envelopment analysis, the study sought answers to three related
questions:
 how well does the UK BSP overall, and individual units within it, perform?;
 does efficiency differ by size of screening unit?; and
 can the performance of individual units be improved upon within existing
resource constraints?
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4. Methods
4.1. Setting
In 1996 the UK BSP was delivered through 97 local breast screening units.
Although mandatory activity-based information is collected from all units and
routinely published (e.g. [3]), this data base lacks certain key information about the
inputs of screening units to enable investigation of local production processes. A
range of potentially relevant input data was obtained from a national survey of
local screening policies and practices [6]. The survey produced a good response rate
(from 82 (87%) of the UK screening units) and was consequently used to identify
the set of screening units to be included in this study. As noted in the introduction,
the potential for either very high or very low cancer detection rates across screening
units causes problems in interpreting the cancer detection rates. This meant that
very small units, i.e. those screening fewer than 1000 women annually, have to be
omitted from the analysis. Fourteen were excluded on this basis. A further four had
missing data and were excluded. The number of screening units included was
thereby reduced to 64.
As the Forrest Committee had suggested a screening size of 41 150 eligible
population, this was used as a guide to stratify screening units into small and large.
A breast screening unit was classed as a small if it served less than 50 000 eligible
women and large if over this level. This led to 33 small units and 31 large.
4.2. Specification of DEA model
To specify a suitable DEA model the decisions relating to the breast screening
production process had to be taken. These relate to: (i) the selection of the most
appropriate input and output variables; (ii) whether to apply weight restrictions on
certain variables; and (iii) the choice of optimisation method. By using different
parameters to identify a series of models under (i)–(iii) specification tests were
conducted to identify the best model. These tests are reported in detail elsewhere
[13]. The DEA software package, Frontier Analyst [14], was used to generate
efficiency scores, score rankings and to identify peers and targets. The statistical
package SPSS v10.0 allowed descriptive statistics and statistical tests to be pre-
sented. Parametric tests were used to compare descriptive variables by size of
screening unit and non-parametric tests to compare skewed efficiency scores.
4.3. Selection of outputs and inputs
Efficiency scores are highly sensitive to the inputs and outputs included. There-
fore careful selection of the most appropriate inputs and outputs to characterise the
breast screening production process is an important step.
The ideal output would be the sum of the number of true negatives and true
positives. This would require data on the sensitivity and specificity of screening for
each radiologist within each screening centre. This information is not recorded in
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the KC-62 returns and thus alternative output specifications had to be considered.
There were four potential outputs of breast screening: number of invitations,
screens, assessments and cancers detected. Screening units should aim to maximise
the number of invitations, screens and the number of cancers detected. They should
not, however, attempt to maximise the number of assessments since a high number
of assessments may reflect poor film reading or inability to detect cancers. Assess-
ments can therefore be viewed as inputs to the production of cancers detected
rather than outputs reducing the outputs included to three: invitations, screens and
cancers detected. Cancers detected were based on cancer detection rates for women
aged 50–54 (the prevalent round) and were corrected for background incidence
using the Blanks and Moss correction factor [4]. The corrected cancer detection
rates were then applied to all women screened and multiplied by 1000 to give the
expected number of cancers detected.
The survey identified a total of 22 potential inputs. A degree of freedom problem
can arise if the sum of the number of inputs or outputs is too large, relative to the
number of units in the sample [15]. As a result, the model may be unable to
discriminate in terms of the efficiency of units. Consequently, a means of reducing
the number to reflect core inputs was identified based on: (i) excluding one input,
if high correlations existed between particular inputs [16]; and (ii) combining inputs
if inputs act as complements (for example, if different grades of staff perform the
same task) [17].
High correlations were found between dedicated mammography machines and
the number of mobile vans. Consequently only dedicated mammography machines
were included. The number of whole time equivalent (WTE) medical and nursing
staff engaged in assessment and the number of assessments were not highly
correlated and therefore both were included. Complementary staff were combined
over staff grades to reduce the number of staff inputs: WTE radiologists, radiogra-
phers, administration staff, and medical and nursing staff engaged in assessment
(assessment team). The total number of inputs included was therefore reduced to
six: number of WTE radiologists, radiographers, administration staff, medical and
nursing staff engaged in assessment work, number of dedicated mammography
machines and assessments performed.
4.4. Weight restrictions
Weight restrictions in DEA are designed to eliminate situations where excep-
tional efficiency scores can be obtained from performance on a single input or
output. Such restrictions are added by the analyst to ensure that certain inputs or
outputs are taken into consideration at least to some extent [18–20]. Minimum
weights of 20% were placed on two key variables: number of cancers detected and
number of WTE radiologists. The former was chosen since cancer detection is the
major activity of a screening unit, so for a unit to be judged without taking this into
account would be misleading. The latter was chosen as, given the current shortage
of radiologists, this was one input which units should be judged on with respect to
efficiency.
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4.5. Optimisation method
As the interest was in how inputs could be used better, an input minimisation
model was selected. This allows the analyst to determine the extent to which a unit
can reduce inputs while maintaining the current level of outputs. The constant
return to scale (CRS) model assumes that one unit of input results in one unit of
output. The variable returns to scale (VRS) model assumes that one unit of input
can result in less than one unit of output (diseconomies of scale), or more than one
unit of output (economies of scale). There is no theoretically correct optimisation
method [21] but the advantage of the VRS model is that scale efficiencies can be
identified. It may however have less discriminatory power than the CRS model as
it identifies more efficient firms than CRS. A VRS specification was used as the
main model but a CRS model was adopted to identify the number of units
operating at CRS within the VRS model [22].
5. Results
The efficiency scores obtained relate to 64 breast screening units of the UK BSP.
This sample represents 66% of all units within the programme or 67% of units
located in England, 71% in Scotland, all Welsh units and no Northern Ireland
units. Thirty-one screening units (48%) were classified as large units, mean size of
83 301 eligible women. Thirty-three units (55%) were classified as small units,
corresponding mean size of 36 618 eligible women (see Table 1). The smallest unit
Table 1
Size of target population, observed inputs and outputs by size of screening unita
Large units 95% confidencet-test meanSmall units
(n31) difference(n33) interval
Target population
36 618Mean 83 301
Range 52 000–145,000 18 000–49 900
Mean (SD) Mean (SD)Inputs
1.2 (0.4) 0.7 (0.7)WTE radiologist 0.50 0.22–0.78
3.63–5.294.463.4 (1.0)WTE radiographers 7.9 (2.1)
6.5 (2.1) 3.3 (1.2)WTE administration 3.33 2.35–4.09
1.8 (0.9) 1.1 (1.1) 0.62WTE assessment team 0.11–1.13
1109 (578) 501 (203)No. assessments 607 385–830
1.38–2.55No. mammography 4.2 (1.4) 2.3 (0.8) 1.96
machines
Outputs
11 931 (3408)26 580 (8014)No. invitations 11 605–17 69314 649
19 813 (5855) 9572 (2695)No. screens 10 240 7916–12 565
91.4 (51)No. cancers detected 29.3–69.949.541.8 (23)
a Note : WTEwhole time equivalent numbers.
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Table 2
Efficiency scores generated under variable returns to scale modela
Minima RankingMedian (IQR) Units operating at CRSGrouping Mean (SD)
91.2 (67.9–100) 28.0 100 2582.1 (20)All units
(n64)
80–99 12
60–79 17
40–59 7
B40 3
92.1 (14)Large unit 100 (86.9–100) 51.0 100 19 13 (42%)
(n31)
80–99 8
60–79 2
40–59 2
84.5 (18)Small unit 95.6 (67.6–100) 48.0 100 15 7 (21%)
(n33)
80–99 5
60–79 9
40–59 4
a Mann–Whitney U value, 389.0; P-value 0.076.
provided a service to a target population of 18 000 women, the largest unit was to
145 000.
Additional information presented in Table 1, adjusted for group size, is for mean
observed values for the six inputs and the three outputs selected to describe and
analyse breast screening production. Aside from a mean difference in the use of
assessment teams that was found to be statistically insignificant between groups,
remaining differences in mean values were statistically significant. For example, on
the output side, a mean of 26 580 invitations were sent from large units. This
resulted in a mean response of 19 813 screens being performed (average uptake rate
74%) and 91.4 breast cancers detected per 10 000 screens taken. Corresponding
activity for smaller units was, on average, 16 903 invitations sent to eligible women,
an average of 9572 women being screened per year (average uptake rate 56%) and,
on average, 41.8 cancers detected per 10 000 women screened. Differences are also
found in the way inputs are combined between small and large units.
Table 2 reports the relative efficiency under a VRS model of the breast screening
programme overall and grouped by size of unit. These data allow analysis of
performance of the average screening unit and individual units within the sample.
A mean efficiency score of 82.1 (or median score of 91.2) was estimated overall.
Thus, on average, if production practices in all screening units had followed the
best practice of the 25 most efficient units identified, then mean outputs would have
been produced using only 82.1% of mean inputs. Instead, the data identify 39 units
under-performing to some extent when compared to peers. Twelve units were
credited with an efficiency score ranging between 80 and 99; 17 units scored
between 60 and 79; seven units between 40 and 59 and three less than 40% the
efficiency of best practice counterparts. The least efficient unit had a score of 28.0.
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The efficiency scores by group size altered the measures of central tendency and
spread but these differences were of borderline statistical significance. The mean
efficiency score for large units was 92.1% implying that 7.9% of inputs could have
been saved in the process of producing observed outputs through best practice.
Similarly, a mean efficiency for smaller units of 84.5% implies that 15.5% of inputs
could have been saved. The spread of scores was wider for the small group but the
Mann–Whitney U-test to compare score ranks by group size suggested no evidence
to support differences in efficiency by size of screening unit (P0.076). The
proportion of units operating at constant returns to scale differed by size of
screening unit (42% of the large units and 21% of the small units), but this
difference was not statistically significant.
Table 3 details the performance of one breast screening unit to demonstrate how
managers of local services and other decision makers can use the results of DEA as
an aid to finding local solutions to better performance. It shows the profile of actual
inputs used by Unit A (a unit with an efficiency score of 61.6%). It compares the
actual level to a target level estimated from the performance of efficient peers. For
example, the following resource use could be improved in order to improve
efficiency: reduce WTE radiographers from 6.7 WTE to 4.2 WTE and reduce WTE
administration staff from 8.5 WTE to 4.9 WTE. The targets can be used as a
starting point for local managers to identify whether improvements in input use are
realisable and to identify feasible options and solutions.
6. Discussion
Information on uptake, recall and cancer-detection rates provides limited infor-
mation on the performance of breast screening units as it ignores the use of inputs
and the relationship between inputs and outputs. To overcome this, a measure of
efficiency, that is a measure of how to minimise the use of inputs whilst maintaining
output, is required. Data envelopment analysis (DEA) has been used to assess such
efficiency. It is a useful technique since, as well as incorporating multiple inputs and
outputs, it compares the efficiency of units compared to their peers and can also
identify where efficiency gains can be made.
Table 3
Potential efficiency gain for Unit A (efficiency score of 61.6%)
Actual levelInputs Target level
WTE Radiologist 0.9 0.5
WTE Radiographers 4.26.7
WTE Administration 8.5 4.9
WTE Assessment team 2.7 0.9
3Mammography machines 4
630Assessments 1022
K. Johnston, K. Gerard : Health Policy 56 (2001) 21–32 31
The results found no evidence to support systematic differences in efficiency by
size of screening unit. This implies that there are no greater technological advan-
tages or divisions of labour from the larger scale production process of a large
screening unit. Although smaller size units may be considered preferable if they are
more accessible to users, in the context of breast screening this is not the case,
however, since both large and small units can use mobile units and this makes
screening unit services more accessible. Although efficiency of screening units does
not differ by size of screening unit, inefficiencies are present in both small and large
screening units. This suggests there is room for improvement in the use of resources
at inefficient screening units. These improvements can be informed by using the
targets identified from the DEA. These targets can be used as a starting point for
local managers to identify whether improvements in resources use are realisable as
well as feasible. For example, a regional solution could be found with local
screening units sharing radiologists. Currently there are no financial incentives in
the provision of breast screening rewarding efficient units. One way of ensuring
units meet targets would be to introduce financial incentives.
One limitation of DEA is that no account is taken of any random error in the
efficiency scores and any deviations from the efficiency frontier are assumed to be
due to inefficiency. This simplification arises to overcome problems of specifying
functional forms. DEA is increasingly being used in a health care context, for
example, to address the efficiency of acute hospitals. In that context, criticisms of
the method often stem from the difficulty of taking case-mix into account. In the
context of breast screening, however, case-mix is not an issue since the outputs of
breast screening (invitations, screening and cancers detected) are homogeneous.
Although the output measures of breast screening used in this study do not reflect
final outcomes or quality of output, this limitation is common to all DEA in health
care. The focus on intermediate outputs, however, does still provide useful informa-
tion on efficiency. A limitation of the study is that screening units that screen fewer
than 1000 women per year could not be included as this would have led to
misleading cancer detection rates and have introduced bias. One way of overcoming
this would have been to exclude cancers detected as an output, but this would then
ignore one of the key outputs, and indeed the main objective of breast screening. In
the future, an alternative might be to aggregate data over a number of years so that
the number of screens goes over the 1000 threshold. Future studies could explore
any changes in efficiency over time by collecting data on inputs and outputs over
a number of years.
This study has shown that there is scope for certain individual screening units to
improve their resource use substantially. Since both large and small units operate at
variable returns to scale, the source of inefficiency may not relate to scale. It will be
necessary for decision makers to examine the practices of individual screening units
before determining feasible options for improving resource use. DEA can help to
identify these feasible options and analysis of this kind should be encouraged and
could, for example, be used to examine the efficiency of other national screening
programmes. The implication of inefficient screening units is that they are using too
many resources and consequently cannot be minimising costs.
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